Rapamycin-induced autophagy activity promotes bone fracture healing in rats
Open Access
- 27 July 2015
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 10 (4), 1327-1333
- https://doi.org/10.3892/etm.2015.2660
Abstract
Autophagy is a crucial mediating process for normal bone cell function and metabolism in physiology or pathology. Rapamycin has been demonstrated to induce the autophagy pathway by inhibiting the mammalian target of rapamycin (mTOR) pathway. However, the contribution of autophagy in orthopedic diseases is rarely reported. The aim of the present study was to evaluate the capacity of pharmacologically induced autophagy to modify disease function in a rat model of bone fracture. A femur fracture model was established via surgery in adult male Sprague-Dawley rats. Rapamycin (n=63 rats) or dimethyl sulfoxide (DMSO) vehicle control (n=63 rats) was administered intraperitoneally for 2, 4 and 6 weeks, and 21 randomly selected rats were sacrificed in each group at each time point. X-ray micro-computed tomography and hematoxylin and eosin staining were used to evaluate the extent of fracture healing in each group. The effects of rapamycin on autophagy, mTOR signaling and the expression levels of vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) were analyzed using immunohistochemistry, immunofluorescence staining and western blot analysis. Rapamycin affected the mTOR signaling pathway in rats following fracture, as indicated by the inhibition of the phosphorylation of ribosomal protein S6, a target of mTOR, and activation of microtubule-associated protein 2 light chain 3, a key marker of autophagy. Histomorphometry and image examination indicated that the number of osteoblasts in each section was significantly (P<0.01) increased in the rapamycin group compared with the control group, and this was associated with a significant (P<0.05) increase in mineralized callus fraction. Furthermore, rapamycin treatment increased the expression levels of VEGF and PCNA in the rat callus tissue. These results suggest that rapamycin may serve a beneficial function in fracture healing, and that the underlying mechanism may involve the activation of autophagy.Keywords
This publication has 40 references indexed in Scilit:
- mTOR: from growth signal integration to cancer, diabetes and ageingNature Reviews Molecular Cell Biology, 2010
- Pathway-based genome-wide association analysis identified the importance of regulation-of-autophagy pathway for ultradistal radius BMDJournal of Bone and Mineral Research, 2010
- Autophagy is a protective mechanism in normal cartilage, and its aging‐related loss is linked with cell death and osteoarthritisArthritis & Rheumatism, 2010
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- Autophagy Suppresses Tumorigenesis through Elimination of p62Cell, 2009
- Rapamycin affects early fracture healing in miceBritish Journal of Pharmacology, 2008
- Autophagy fights disease through cellular self-digestionNature, 2008
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- Suppression of basal autophagy in neural cells causes neurodegenerative disease in miceNature, 2006
- Impairment of starvation-induced and constitutive autophagy in Atg7-deficient miceThe Journal of cell biology, 2005